A survey of the humoral immune response of cancer patients to a panel of human tumor antigens

Journal of Experimental Medicine

Volumn 187, Issue 8, 1998, Pages 1349-1354

  Stockert, Elisabeth ^a   Jäger, Elke ^b   Chen, Yao Tseng ^a,c   Scanlan, Matthew J ^a   Gout, Ivan ^d   Karbach, Julia ^b   Arand, Michael ^e   Knuth, Alexander ^b   Old, Lloyd J ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b KRANKENHAUS NORDWEST   (Germany)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; RECOMBINANT PROTEIN; TUMOR ANTIGEN;

ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER IMMUNOLOGY; COLON CANCER; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; LUNG CANCER; MAJOR CLINICAL STUDY; MELANOMA; OVARY CANCER; PRIORITY JOURNAL;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; AUTOANTIBODIES; BREAST NEOPLASMS; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUNG NEOPLASMS; MELANOMA; MEMBRANE PROTEINS; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; NEOPLASMS; OVARIAN NEOPLASMS; PROTEINS; RECOMBINANT PROTEINS; REPRESSOR PROTEINS;

EID: 2642673605     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.8.1349     Document Type: Article

References (29)

1. Oettgen, H.F., and L.J. Old. 1991. The history of cancer immunotherapy. In Biologic Therapy of Cancer. V.T. De Vita, S. Hellman, and S.A. Rosenberg, editors. J.B. Lippincott Company, Philadelphia. 87-119.
2. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725-729.
3. Old, L.J. 1981. Cancer immunology: the search for specificity. G.H.A. Clowes memorial lecture. Cancer Res. 41:361-375.
4. Knuth, A., B. Danowski, H.F. Oettgen, and L.J. Old. 1984. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc. Natl. Acad. Sci. USA. 81:3511-3515.
5. Sahin, U., Ö. Türeci, H. Schmitt, B. Cochlovius, T. Johannes, R. Schmitts, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA. 92:11810-11813.
6. Chen, Y.-T., M.J. Scanlan, U. Sahin, Ö. Türeci, A.O. Gure, S. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L.J. Old. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA. 94:1914-1918.
7. Labrecque, S., N. Naor, D. Thomson, and G. Matlashewski. 1993. Analysis of the anti-p53 antibody response in cancer patients. Cancer Res. 53:3468-3471.
8. Wölfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wölfel, E. Klehmann-Hieb, E. De Plaen, T. Hankeln, K.-H. Meyer zum Buschenfelde, and D. Beach. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269:1281-1284.
9. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178:489-495.
10. Robbins, P.F., M. El-Gamil, Y. Kawakami, and S.A. Rosenberg. 1994. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res. 54:3124-3126.
11. Coulie, P.G., V. Brichard, A. Van Pel, T. Wölfel, J. Schneider, C. Traversari, S. Mattei, E. De Plaen, C. Lurquin, J.P. Szikora, et al. 1994. A new gene coding for a differentiation antigen recognized by autologous cytolytic lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
12. Cheever, M.A., M.L. Disis, H. Bernhard, J.R. Gralow, S.L. Hand, E.S. Huseby, H.L. Qin, M. Takahashi, and W. Chen. 1995. Immunity to oncogenic proteins. Immunol. Rev. 145: 33-59.
13. Boller, K., O. Janssen, H. Schuldes, R.R. Tonjes, and R. Kurth. 1997. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J. Virol. 71:4581-4588.
14. Tindle, R.W. 1996. Human papillomavirus vaccines for cervical cancer. Curr. Opin. Immunol. 8:643-650.
15. Lennette, E.T., G. Winberg, M. Yadav, G. Enblad, and G. Klein. 1995. Antibodies to LMP2A/2B in EBV-carrying malignancies. Eur. J. Cancer. 31:1875-1878.
16. Türeci, Ö., U. Sahin, and M. Pfreundschuh. 1997. Serological analysis of human tumor antigens: molecular definition and implications. Molec. Med. Today. 3:342-349.
17. Chen, Y.-T., E. Stockert, Y. Chen, P. Garin-Chesa, W.J. Rettig, P. van der Bruggen, T. Boon, and L.J. Old. 1994. Identification of the MAGE-1 gene product by monoclonal and polyclonal antibodies. Proc. Natl. Acad. Sci. USA. 91: 1004-1008.
18. Chen, Y.-T., E. Stockert, A. Jungbluth, S. Tsang, K.A. Coplan, M.J. Scanlan, and L.J. Old. 1996. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc. Natl. Acad. Sci. USA. 93:5915-5919.
19. Chen, Y.-T., E. Stockert, S. Tsang, K.A. Coplan, and L.J. Old. 1995. Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc. Natl. Acad. Sci. USA. 92:8125-8129.
20. Kwon, B.S., A.K. Haq, S.H. Pomerantz, and R. Halaban. 1987. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc. Natl. Acad. Sci. USA. 84:7473-7477.
21. Türeci, Ö., U. Sahin, I. Schobert, M. Koslowski, H. Schmitt, H.J. Schild, F. Stenner, G. Seitz, H.G. Rammensee, and M. Pfreundschuh. 1996. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56:4766-4772.
22. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
23. Rosenberg, S.A. 1996. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J. Natl. Cancer Inst. 88:1635-1644.
24. Hoon, D.S., M. Yazuki, M. Hayashida, and D.L. Morton. 1995. Melanoma patients immunized with melanoma cell vaccine induce antibody responses to recombinant MAGE-1 antigen. J. Immunol. 154:730-737.
25. Jäger, E., Y.-T. Chen, J.W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jäger, M. Arand, H. Wada, Y. Noguchi, E. Stockert, et al. 1998. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of HLA-A2 binding peptide epitopes. J. Exp. Med. 187:265-270.
26. Kitamura, K., P.O. Livingston, S.R. Fortunato, E. Stockert, F. Helling, G. Ritter, H.F. Oettgen, and L.J. Old. 1995. Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine. Proc. Natl. Acad. Sci. USA. 92:2805-2809.
27. Marchand, M., P. Weymants, E. Rankin, F. Anenti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwijk, Y. Humblet, et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer. 63:883-885.
28. Jäger, E., H. Bernhard, P. Romero, M. Ringhoffer, M. Arand, J. Karbach, C. Ilsemann, M. Hagedorn, and A. Knuth. 1996. Generation of cytotoxic T cell responses with synthetic melanoma associated peptides in vivo: implications for tumor vaccines with melanoma associated antigens. Int. J. Cancer. 66:162-169.
29. Jäger, E., M. Arand, M. Ringhoffer, J. Karbach, D. Jäger, C. Ilsemann, M. Hagedorn, F. Oesch, and A. Knuth. 1996. Cytolytic T cell reactivity against melanoma associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma Res. 6:419-425.